Congress needs to increase the FY22 base budgets of NIH and NCI by $3.2 billion and $1.1 billion, respectively, over FY21 levels, the American Association for Cancer Research said in its 2021 Cancer Progress Report.
These increases would result in a total funding level of $46.1 billion for NIH and $7.6 billion for NCI.
“The truth of the matter is the payline at the NCI is crippling,” David A. Tuveson, AACR President and Roy J. Zuckerberg Professor of Cancer Research at Cold Spring Harbor Laboratory, said to The Cancer Letter. “We have a grant funding crisis because we have success in the therapies that we’ve been giving our patients.”
